Concepedia

Publication | Open Access

Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients

43

Citations

30

References

2020

Year

Abstract

Pretreatment NLR and mGPS might be predictive markers of survival in patients with R/M SCCHN treated with nivolumab.

References

YearCitations

Page 1